Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...
New York State Psychiatric Institute and Columbia University Medical Center investigators, with co-authors across additional ...
Credit: Getty Images. Although valganciclovir is an effective CMV prophylactic agent after kidney transplantation, it is associated with significant side effects. Valacyclovir (valA) is effective and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback